Clinical Trials Logo

Clinical Trial Summary

A study in adolescents and adults with eosinophilic esophagitis (EoE) to measure the histologic response and determine if any reduction in dysphagia is achieved.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02605837
Study type Interventional
Source Takeda
Contact
Status Completed
Phase Phase 3
Start date December 7, 2015
Completion date February 15, 2019

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04394351 - Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE) Phase 3
Terminated NCT03245840 - Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE) Phase 3
Completed NCT03581838 - Eating With Eosinophilic Esophagitis (EoE)
Completed NCT02778867 - SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study Phase 2/Phase 3
Completed NCT01642212 - OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension Phase 2
Completed NCT05485779 - SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects Phase 1
Recruiting NCT04626609 - Prostaglandin and Cannabinoid Receptors in EoE
Completed NCT00762073 - Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic Esophagitis Phase 2
Terminated NCT02058537 - Bethanechol for Eosinophilic Esophagitis Phase 2
Completed NCT02320981 - Mucosal Impedance in Pediatric Population N/A
Recruiting NCT06389994 - Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
Completed NCT02736409 - An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE) Phase 3